Bicarbonate

Bicarbonate

SCHEMBL7609450

O=C([O-])O.O=C([O-])O.O=C([O-])O.[CaH2].[Mg+2].[Na+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.50
FAHD1 Q6P587 1/20 0.50
CA1 P00915 3/20 0.46
MEN1 O00255 1/20 0.40
LDHA P00338 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 2/20 0.38
CASP1 P29466 1/20 0.38
CA2 P00918 2/20 0.36
CA9 Q16790 1/20 0.36
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL28012376 0.95 CA4 (0.55) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL9487740 0.95 CA4 (0.42) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL6150818 0.90
Bicarbonate SCHEMBL7913933 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL28946762 0.90 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL18420704 0.89 CA4 (0.46) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL15249 0.89
Bicarbonate SCHEMBL5403678 0.89 CA4 (0.60) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL10646323 0.89 CA4 (0.60) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL15321596 0.89 CA4 (0.60) CA4FAHD1CA1MEN1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192181-A1 METHODS FOR MODULATING ANGIOGENESIS BY USING THE ANTI-ANGIOGENIC ANGIOTENSIN-7 AND POLYNUCLEOTIDES ENCODING THEREFOR BAYER AG (DE) 2002-04-03 EP disclosed
WO-2001002434-A1 METHODS FOR MODULATING ANGIOGENESIS BY USING THE ANTI-ANGIOGENIC ANGIOTENSIN-7 AND POLYNUCLEOTIDES ENCODING THEREFOR BAYER AG (DE) 2001-01-11 WO disclosed